Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BIO-TECHNE Corp (TECH) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BIO-TECHNE Corp (TECH), most recent 12 months reported: revenue $1.22B, net income $181.86M, free cash flow $263.22M. Latest balance sheet on file: liquid cash $264.71M, total debt $200M, net cash $64.71M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Exelixis Inc · Moderna, Inc. · QIAGEN N.V. · HALOZYME THERAPEUTICS, INC. · BIOCRYST PHARMACEUTICALS, INC. · REPLIGEN CORP · TARSUS PHARMACEUTICALS, INC. · ADMA BIOLOGICS, INC.

Stock screener

Watchlist